Try our Advanced Search for more refined results
Genzyme Corporation v. Impax Laboratories, Inc.
Case Number:
1:09-cv-00653
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 05, 2012
Genzyme, Impax Bury Hatchet Over Kidney Disease Drugs
Impax Laboratories Inc. on Tuesday settled patent infringement claims brought by Sanofi-Aventis SA subsidiary Genzyme Corp. over plans to make generic versions of two Genzyme kidney disease treatments, reaching a deal that will give Impax licensing rights in 2014.
-
September 03, 2009
Endo Looks To Join Genzyme-Impax Renagel Battle
Endo Pharmaceuticals Inc. has asked a court for permission to intervene in Genzyme Corp.'s Renagel patent infringement case against Impax Laboratories Inc., arguing that Impax challenged a second patent's validity solely in a bid to force first-filer Endo to forfeit its exclusivity period.